Ex Parte Spangenberg et alDownload PDFPatent Trial and Appeal BoardAug 4, 201613063992 (P.T.A.B. Aug. 4, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/063,992 03/15/2011 57381 7590 Larson & Anderson, LLC P.O. BOX 4928 DILLON, CO 80435 08/04/2016 FIRST NAMED INVENTOR German Spangenberg UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. JOTL.P-017 8089 EXAMINER DEVEAU ROSEN, JASON ART UNIT PAPER NUMBER 1662 MAILDATE DELIVERY MODE 08/04/2016 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte GERMAN SP AN GENBERG, AIDYN MOURADOV, MEGAN ELIZABETH GRIFFITH, and LUCIANO GASTON MARTELOTTO Appeal2014-008645 Application 13/063,992 Technology Center 1600 Before CHRISTOPHER G. PAULRAJ, JACQUELINE T. HARLOW, and JOHN E. SCHNEIDER, Administrative Patent Judges. P AULRAJ, Administrative Patent Judge. DECISION ON APPEAL This is an appeal 1 under 35 U.S.C. § 134 involving claims to a genetic construct and a method of transforming plants with such a construct. The Examiner rejected the claims for obviousness. We have jurisdiction under 35 U.S.C. § 6(b). We reverse. 1 Appellants identify the Real Party in Interest as Agriculture Victoria Services Pty Ltd. (See Appeal Br. 1 ). Appeal2014-008645 Application 13/063,992 STATEMENT OF THE CASE Background According to the Specification, "Applicants have found that it is possible to nutritionally enhance plants eg. forage grasses and/or to increase plant biomass by spatial reprogramming of the fructan-biosynthesis pathway in photosynthetic cells." Spec. 3, 11. 2--4. The Specification notes that "it is thought that by bringing two enzymes in a pathway into close proximity, for example by expressing a translational fusion, expression of the individual enzymes may be co-ordinated thereby improving the efficiency of the pathway." Id. at 11. 26-29. The Specification further notes that by expressing a translational fusion of two or more FT genes (e.g. Lpl-SST and Lp6G-FFT), problems associated with differences in the expression patterns of these genes independently integrated into the plant genome may be alleviated, resulting in conversion of the sucrose molecules directly to fructans, those exhibiting a low degree of polymerisation ('low DP fructans') and a high degree of polymerization ('high DP fructans'). Furthermore, the FT proteins may physically associate with each other to form a metabolic channel for the efficient biosynthesis of fructans. Id. at 4, 11. 1-7. The claimed invention seeks to achieve the foregoing with a genetic construct encoding a fusion protein of two or more fructan- biosynthetic enzymes whose expression is controlled by a light-regulated promoter. Id. at 14. The Claims Claims 39, 40, 45, 49, and 52-56 are on appeal. Independent claim 56 is representative and reads as follows: A genetic construct, said genetic construct including a light-regulated promoter operatively linked to nucleic acids encoding two or more fructan biosynthetic enzymes, wherein 2 Appeal2014-008645 Application 13/063,992 said nucleic acids are linked to form a fusion gene encoding a fusion protein of said two or more enzymes. The Rejections The Examiner has rejected the claims as follows: I. Claims 39, 40, 45, and 53-56 under 35 U.S.C. § 103(a) as being unpatentable over Pilon-Smits, 2 Koops, 3 Tian, 4 and Shimizu- Sato. 5 II. Claims 49 and 52 under 35 U.S.C. § 103(a) as being unpatentable over Pilon-Smits, Koops, Tian, and Shimizu-Sato, and further in view of Spangenberg. 6 ANALYSIS Because it is dispositive as to all issues on appeal, we focus our analysis on the rejection of independent claim 56, which is directed to the genetic construct. Independent claim 55 recites a method that utilizes the same genetic construct. The Examiner finds that Pilon-Smits teaches a sugar beet transformed with a genetic construct consisting of a constitutive promoter operatively linked to a nucleic acid sequence encoding the 6-SFT enzyme, and that the expression of this gene construct in sugar beet plants leads to the selection of 2 Pilon-Smits et al., Enhanced drought resistance infructan-producing sugar beet, 37 Plant Physiol. Biochem. 313-317 (1999) ("Pilon-Smits"). 3 Koops et al., US 6,664,444 B 1, issued Dec. 16, 2003 ("Koops"). 4 Tian and Dixon, Engineering isoflavone metabolism with an artificial bifunctional enzyme, 224 Planta 496-507 (2006) ("Tian"). 5 Shimizu-Sato et al., A light-switchable gene promoter system, 20 Nature Biotechnology 1041-1044 (2002) ("Shimizu-Sato"). 6 Spangenberg et al., US 7,227,055 B2, issued June 5, 2007 ("Spangenberg"). 3 Appeal2014-008645 Application 13/063,992 transfonnants with enhanced biomass. Ans. 3. The Examiner further finds that Koops teaches: a genetic construct capable of manipulating fructan biosynthesis in photosynthetic cells of a plant wherein the construct is chimeric (col. 23; Example 8) and includes the enhanced CaMV35S (Penh35S) promoter (col. 14 bridging col. 15, lines 66-67 and line 1) operably linked to the a33 gene coding for 1- SST (col. 6, lines 25-29) and the c86 gene coding for 1-FFT (col 6, lines 38-44). Id. at 4. The Examiner acknowledges that neither Pilon-Smits nor Koops teaches a) a fusion gene encoding a fusion protein of two or more fructan biosynthetic enzymes orb) the use of a light-regulated promoter. The Examiner relies upon Tian and Shimizu-Sato to make up for these deficiencies. We determine that the Examiner has not made a prima facie showing of obviousness. First, with respect to the requirement of a fusion gene encoding for a fusion protein, the Examiner has not sufficiently taken into account the unpredictability associated with the expression of fusion genes, as recognized by Tian. For example, Tian teaches that an in-frame fusion of thiolase and reductase genes was constructed for polyhydroxybutyrate biosynthesis, but "plants transformed with this construct produced less polyhydroxybutyrate than plants expressing thiolase and reductase individually." Tian, 497, col. 2. Tian further teaches that "[a] direct head to tail fusion of two proteins together often restrains the correct folding of the individual components, and hence leads to non-functional or mal-functional enzymes." Id. at 503, col. 2. As such, the Examiner has not shown that the skilled artisan would have a reasonable expectation of success in 4 Appeal2014-008645 Application 13/063,992 extrapolating Tian's teachings regarding an IFS/CHI fusion protein to other plant biosynthesis enzymes, and in particular to a fusion gene encoding for the fructan biosynthesis enzymes required by the claimed genetic construct. Second, with respect to the requirement for a light-regulated promoter, the Examiner asserts that "one of ordinary skill in the art would be motivated to control the expression of fructan biosynthetic genes under the control of a light inducible promoter as taught by Shimizu-Sato because different and precise levels of inulin can be produced." Ans. 10. The Examiner, however, has not provided a reason why the skilled artisan would want to control the production of inulin in such a manner. In particular, we agree with Appellants that "the Examiner has not said why part time expression, or expression only in certain plant parts [i.e., spatiotemporal control] is desirable for the purposes of the other references." Appeal Br. 6. For example, the Examiner has not shown that the skilled artisan would be concerned with either over-expression or under-expression of fructan- biosynthesis enzymes in the transgenic plants discussed in Koops or Pilon- Smits, which could be remedied by the use of a light-regulated promoter. For the foregoing reasons, we reverse the obviousness rejection of claims 39, 40, 45, and 53-56 based on the combination of Pilon-Smits, Koops, Tian, and Shimizu-Sato. Additionally, the Examiner has not shown that the teachings of Spangenberg make up for the foregoing deficiencies in the primary rejection, and therefore we also reverse the obviousness rejection of claims 49 and 52. 5 Appeal2014-008645 Application 13/063,992 SUMMARY We reverse the rejections under 35 U.S.C. § 103(a). REVERSED 6 Copy with citationCopy as parenthetical citation